Literature DB >> 12853114

Differential kinetics of hypocretins in the cerebrospinal fluid after intracerebroventricular administration in rats.

Yasushi Yoshida1, Nobuhiro Fujiki, Richard A Maki, David Schwarz, Seiji Nishino.   

Abstract

Different potencies for hypocretin-1 and -2 in sleep-wake regulation and feeding after intracerebroventricular (ICV) administration have been reported. These differences were often explained by the selectivity of the two hypocretins for hypocretin receptor-1 and -2, but little attention has been paid to kinetics of hypocretin peptides. We investigated the kinetics of the ICV hypocretin-1 and -2 in rats. ICV hypocretin-1 (10 nmol) increased hypocretin-1 peptide level in the CSF by 800-fold from baseline with the elevation lasting over 4 h. In contrast, after ICV hypocretin-2 (10 nmol), no significant rise in the CSF was found. CSF hypocretin levels were significantly correlated with the biological activities of CSF hypocretin-1 and -2 using the Ca(2+) mobilization assay. Difference in the kinetics of hypocretins should be considered for interpreting ICV effects of hypocretins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853114     DOI: 10.1016/s0304-3940(03)00571-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Orexin/hypocretin receptor signalling: a functional perspective.

Authors:  C S Leonard; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

2.  Orexin A induces GnRH gene expression and secretion from GT1-7 hypothalamic GnRH neurons.

Authors:  Ravid Sasson; Robert K Dearth; Rachel S White; Patrick E Chappell; Pamela L Mellon
Journal:  Neuroendocrinology       Date:  2006-12-28       Impact factor: 4.914

3.  The wake-promoting effects of hypocretin-1 are attenuated in old rats.

Authors:  Stephen R Morairty; Jonathan Wisor; Kristy Silveira; William Sinko; Thomas S Kilduff
Journal:  Neurobiol Aging       Date:  2009-09-24       Impact factor: 4.673

4.  The diurnal rhythm of hypocretin in young and old F344 rats.

Authors:  Frank Desarnaud; Eric Murillo-Rodriguez; Ling Lin; Man Xu; Dmitry Gerashchenko; Samara N Shiromani; Seiji Nishino; Emmanuel Mignot; Priyattam J Shiromani
Journal:  Sleep       Date:  2004-08-01       Impact factor: 5.849

5.  Intraventricular orexin-A improves arousal and early EEG entropy in rats after cardiac arrest.

Authors:  Matthew A Koenig; Xiaofeng Jia; Xiaoxu Kang; Adrian Velasquez; Nitish V Thakor; Romergryko G Geocadin
Journal:  Brain Res       Date:  2008-12-16       Impact factor: 3.252

Review 6.  Focus on the Complex Interconnection between Cancer, Narcolepsy and Other Neurodegenerative Diseases: A Possible Case of Orexin-Dependent Inverse Comorbidity.

Authors:  Maria P Mogavero; Alessandro Silvani; Lourdes M DelRosso; Michele Salemi; Raffaele Ferri
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

7.  Involvement of spinal orexin A in the electroacupuncture analgesia in a rat model of post-laparotomy pain.

Authors:  Xiao-Ming Feng; Wen-Li Mi; Fang Xia; Qi-Liang Mao-Ying; Jian-Wei Jiang; Sheng Xiao; Zhi-Fu Wang; Yan-Qing Wang; Gen-Cheng Wu
Journal:  BMC Complement Altern Med       Date:  2012-11-22       Impact factor: 3.659

8.  Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants.

Authors:  Tohei Yokogawa; Wilfredo Marin; Juliette Faraco; Guillaume Pézeron; Lior Appelbaum; Jian Zhang; Frédéric Rosa; Philippe Mourrain; Emmanuel Mignot
Journal:  PLoS Biol       Date:  2007-10-16       Impact factor: 8.029

9.  Different levels in orexin concentrations and risk factors associated with higher orexin levels: comparison between detoxified opiate and methamphetamine addicts in 5 Chinese cities.

Authors:  Haoran Zhang; Zhi Lian; Shiyan Yan; Yanping Bao; Zhimin Liu
Journal:  Biomed Res Int       Date:  2013-09-12       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.